{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:21:59Z","timestamp":1791267719990,"version":"4.1.0"},"reference-count":61,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T00:00:00Z","timestamp":1375228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Treatment-resistant depression patients show both reduced glucocorticoid receptor function and a hyperactive hypothalamic-pituitary-adrenal axis. However, few studies have examined the role of the mineralocorticoid receptor. This study aimed to evaluate the functional activity of the mineralocorticoid receptor system in regulating the hypothalamic-pituitary-adrenal axis in well-defined treatment-resistant depression patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and method:<\/jats:title>\n                    <jats:p>We recruited 24 subjects divided into: (a) treatment-resistant depression; (b) healthy controls. We evaluated: (a) the effect of combined glucocorticoid receptor\/mineralocorticoid receptor stimulation with prednisolone; (b) the effect of prednisolone with the mineralocorticoid receptor antagonist spironolactone; and (c) the effect of spironolactone alone. The response of the hypothalamic-pituitary-adrenal axis was measured using salivary cortisol and plasma levels of drugs were also measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Treatment-resistant depression patients had higher cortisol compared with controls after all challenges. In controls, spironolactone increased cortisol compared to placebo. The co-administration of spironolactone with prednisolone in controls decreases the suppressive effects of prednisolone. In contrast, in treatment-resistant depression, spironolactone did not increase cortisol compared to placebo and spironolactone with prednisolone had no effect on the suppressive effects of prednisolone. Patients with treatment-resistant depression had a reduction in the conversation of spironolactone to the active metabolite canrenone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our data confirmed that treatment-resistant depression is associated with hypercortisolism and these patients no longer show an hypothalamic-pituitary-adrenal response to the administration of a mineralocorticoid receptor antagonist, suggesting that there is a mineralocorticoid receptor malfunctioning, such as a down regulation, however, pharmacokinetics and pharmacodynamics in these subjects could also have had an effect on the lack of mineralocorticoid receptor response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0269881113499205","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T22:00:51Z","timestamp":1375308051000},"page":"1169-1179","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":57,"title":["The role of mineralocorticoid receptor function in treatment-resistant depression"],"prefix":"10.1177","volume":"27","author":[{"given":"Mario F","family":"Juruena","sequence":"first","affiliation":[{"name":"King\u2019s College London, Institute of Psychiatry, Section of Neurobiology of Mood Disorders, London, UK"},{"name":"King\u2019s College London, Institute of Psychiatry, Stress, Psychiatry and Immunology Laboratory (SPI-Lab), London, UK"},{"name":"Affective Disorders Unit Laboratory, National Affective Disorders Unit, South London and Maudsley NHS Trust, Bethlem Royal Hospital, Beckenham, Kent, UK"},{"name":"Stress and Affective Disorders (SAD) Programme, Department of Neurosciences and Behaviour, Faculty of Medicine Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine M","family":"Pariante","sequence":"additional","affiliation":[{"name":"King\u2019s College London, Institute of Psychiatry, Stress, Psychiatry and Immunology Laboratory (SPI-Lab), London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"Affective Disorders Unit Laboratory, National Affective Disorders Unit, South London and Maudsley NHS Trust, Bethlem Royal Hospital, Beckenham, Kent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Poon","sequence":"additional","affiliation":[{"name":"Affective Disorders Unit Laboratory, National Affective Disorders Unit, South London and Maudsley NHS Trust, Bethlem Royal Hospital, Beckenham, Kent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stafford","family":"Lightman","sequence":"additional","affiliation":[{"name":"Henry Wellcome Laboratories for Integrative Neuroscience & Endocrinology University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J","family":"Cleare","sequence":"additional","affiliation":[{"name":"King\u2019s College London, Institute of Psychiatry, Section of Neurobiology of Mood Disorders, London, UK"},{"name":"Affective Disorders Unit Laboratory, National Affective Disorders Unit, South London and Maudsley NHS Trust, Bethlem Royal Hospital, Beckenham, Kent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,7,31]]},"reference":[{"key":"bibr1-0269881113499205","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"bibr2-0269881113499205","first-page":"3176","volume":"86","author":"Arvat E","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"bibr3-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1159\/000127240"},{"key":"bibr4-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00009-4"},{"key":"bibr5-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1207\/s15327752jpa6703_13"},{"key":"bibr6-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1348\/014466505X35344"},{"key":"bibr7-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.1994.tb01284.x"},{"key":"bibr8-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00539-8"},{"key":"bibr9-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.162"},{"key":"bibr10-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1683"},{"key":"bibr11-0269881113499205","first-page":"269","volume":"19","author":"De Kloet ER","year":"1998","journal-title":"Endocr Rev"},{"key":"bibr12-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1159\/000054384"},{"key":"bibr13-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1159\/000126592"},{"key":"bibr14-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1521\/pedi.1995.9.2.92"},{"key":"bibr15-0269881113499205","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders- Clinician Version (SCID-CV)","author":"First MB","year":"1997"},{"key":"bibr16-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300884"},{"key":"bibr17-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00378.2003"},{"key":"bibr18-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020331"},{"key":"bibr19-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1007\/BF03344031"},{"key":"bibr20-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790320081011"},{"key":"bibr21-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(00)00006-8"},{"key":"bibr22-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(98)90056-5"},{"key":"bibr23-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00159-7"},{"key":"bibr24-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2007.10.005"},{"key":"bibr25-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462004000300009"},{"key":"bibr26-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0555-4"},{"key":"bibr27-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.050278"},{"key":"bibr28-0269881113499205","first-page":"115","volume":"1","author":"Juruena M.F","year":"2010","journal-title":"Mind Brain"},{"key":"bibr29-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2010.04.016"},{"key":"bibr30-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.11.1938"},{"key":"bibr31-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(94)90013-2"},{"key":"bibr32-0269881113499205","first-page":"415","volume":"23","author":"Kocarek TA","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"bibr33-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301260"},{"key":"bibr34-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2012.05.006"},{"key":"bibr35-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00484-8"},{"key":"bibr36-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(99)00129-3"},{"key":"bibr37-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2008.08.004"},{"key":"bibr38-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1159\/000101917"},{"key":"bibr39-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.04.049"},{"key":"bibr40-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(00)00021-2"},{"key":"bibr41-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2009.10.006"},{"key":"bibr42-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1515\/DMDI.1987.5.4.273"},{"key":"bibr43-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00521.2004"},{"key":"bibr44-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01314-2"},{"key":"bibr45-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(85)90004-6"},{"key":"bibr46-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00677-4"},{"key":"bibr47-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1210\/endo-117-6-2505"},{"key":"bibr48-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.11.1618"},{"key":"bibr49-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(93)90072-H"},{"key":"bibr50-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5332-09.2010"},{"key":"bibr51-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.10.1299"},{"key":"bibr52-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1124\/mol.54.6.1113"},{"key":"bibr53-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1210\/endo.139.6.6029"},{"key":"bibr54-0269881113499205","first-page":"23","volume":"58","author":"Thase ME","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"bibr55-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291702005998"},{"key":"bibr56-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0086"},{"key":"bibr57-0269881113499205","volume-title":"Structured Interview Guide for the Hamilton-Depression And Anxiety Scales (SIGH-AD)","author":"Williams JBW","year":"1988"},{"key":"bibr58-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300471"},{"key":"bibr59-0269881113499205","first-page":"3339","volume":"83","author":"Young EA","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"bibr60-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.1.24"},{"key":"bibr61-0269881113499205","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31815c16f5"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881113499205","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0269881113499205","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881113499205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:07:35Z","timestamp":1777507655000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881113499205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,31]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1177\/0269881113499205"],"URL":"https:\/\/doi.org\/10.1177\/0269881113499205","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,31]]}}}